Sinopharm Tech Holdings (HKSE:08156) Scaled Net Operating Assets : -0.36 (As of Dec. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Sinopharm Tech Holdings Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Sinopharm Tech Holdings's operating assets for the quarter that ended in Dec. 2024 was HK$41.34 Mil. Sinopharm Tech Holdings's operating liabilities for the quarter that ended in Dec. 2024 was HK$57.31 Mil. Sinopharm Tech Holdings's Total Assets for the quarter that ended in Jun. 2024 was HK$44.49 Mil. Therefore, Sinopharm Tech Holdings's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was -0.36.

Sinopharm Tech Holdings Scaled Net Operating Assets Historical Data

The historical data trend for Sinopharm Tech Holdings's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Tech Holdings Scaled Net Operating Assets Chart

Sinopharm Tech Holdings Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.16

-0.21

-0.96

-1.67

-4.03

Sinopharm Tech Holdings Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Dec24
Scaled Net Operating Assets	Get a 7-Day Free Trial															-	-	-	-2.92	-0.36

Competitive Comparison of Sinopharm Tech Holdings's Scaled Net Operating Assets

For the Software - Application subindustry, Sinopharm Tech Holdings's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinopharm Tech Holdings's Scaled Net Operating Assets Distribution in the Software Industry

For the Software industry and Technology sector, Sinopharm Tech Holdings's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Sinopharm Tech Holdings's Scaled Net Operating Assets falls into.

Save Embed

;

Save Embed

;

Sinopharm Tech Holdings Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Sinopharm Tech Holdings's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jun. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Jun. 2024 )
=	(Operating Assets (A: Jun. 2024 )	-	Operating Liabilities (A: Jun. 2024 ))	/	Total Assets (A: Jun. 2023 )
=	(41.85	-	176.833)	/	33.482
=	-4.03

where

	Operating Assets		(A: Jun. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	44.49	-	2.64
=	41.85

	Operating Liabilities		(A: Jun. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	250.089	-	0.653	-	72.603
=	176.833

Sinopharm Tech Holdings's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2024 )
=	(Operating Assets (Q: Dec. 2024 )	-	Operating Liabilities (Q: Dec. 2024 ))	/	Total Assets (Q: Jun. 2024 )
=	(41.335	-	57.313)	/	44.49
=	-0.36

where

	Operating Assets		(Q: Dec. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	44.682	-	3.347
=	41.335

	Operating Liabilities		(Q: Dec. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	63.341	-	0.148	-	5.88
=	57.313

Sinopharm Tech Holdings Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Sinopharm Tech Holdings's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinopharm Tech Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Sinopharm Tech Holdings Ltd (HKSE:08156) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ruttonjee Centre, 11 Duddell Street, Unit 1802, 18th Floor, Ruttonjee House, Hong Kong Central, Hong Kong, HKG

Website

https://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Ltd is an investment holding company. The company's operating segment includes Internet Plus services; Supply chain services; and Manufacturing and distribution of personal protective equipment. It generates maximum revenue from Supply chain services segment, which includes provision of supply chain management, data analysis and related services and trading of related goods, and trading of medial and related products. Geographically, it derives a majority of revenue from Hong Kong.

Executives

Chiu Sin Nang Kenny	2201 Interest of corporation controlled by you
Creative Big Limited	2101 Beneficial owner
Integrated Asset Management (asia) Limited	2101 Beneficial owner
Yam Tak Cheung	2201 Interest of corporation controlled by you
Quantum Worldwide Investment Limited	2101 Beneficial owner
Best Frontier Investments Limited
Chan Kin Ho Philip	2201 Interest of corporation controlled by you
Lam Yui Keung	2201 Interest of corporation controlled by you
Sinopharm Traditional Chinese Medicine Overseas Holdings Limited	2101 Beneficial owner
Main Key Investments Limited	2201 Interest of corporation controlled by you
Guo Lei	2201 Interest of corporation controlled by you
Chan Tung Mei	2202 Interest of your spouse
Cheung Kwai Lan	2201 Interest of corporation controlled by you
Tse Siu Hoi	2101 Beneficial owner
Gam Star China Equity (a Sub-fund Of Gam Star Fund P.l.c.)	2102 Investment manager

Sinopharm Tech Holdings Headlines

No Headlines